NCT02471326View on ClinicalTrials.gov

VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 13, 2015

Primary Completion Date

April 7, 2017

Study Completion Date

April 7, 2017

Conditions
HIV
Interventions
BIOLOGICAL

VRC-HIVMAB060-00-AB (VRC01)

A potent HIV-specific monoclonal antibody

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02471326 - VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption | Biotech Hunter | Biotech Hunter